Asia Pacific Blood Market Forecast 2019-2028

Asia Pacific Blood Market Forecast 2019-2028

KEY FINDINGS
The Asia Pacific blood market is predicted to grow with a CAGR of 4.71%, across the forecast period of 2019 to 2028. The major factors driving market growth include, developments in the healthcare industry, and the growing demand for blood, and blood-related products.

MARKET INSIGHTS
The Asia Pacific blood market growth is determined by evaluating China, India, Vietnam, South Korea, Japan, Thailand, Australia & New Zealand, Indonesia, and the rest of the Asia Pacific. The blood market in India is observing steady growth, due to the need for blood-related products and equipment in the nation. According to statistics, nearly 9 million units of whole blood are collected annually in India, with a growth rate of 10%. Besides, it is estimated that the country needs at least 12 million units of blood, and only 1% of eligible volunteers donate each day. Moreover, countless transportation accidents across India, maternal mortality, and seasonal threats like dengue fever during the monsoon, have greatly impacted the need for blood.
On the other hand, website operators in India have developed local pages listing medical facilities, like, walk-in-clinics, hospitals, eye banks, and blood banks, among others. There are also numerous ongoing efforts established to form local associations and alliances of blood banks and other medical groups, throughout the county’s major cities. As a result, due to the increasing awareness regarding blood banks and the importance of storing blood, the country is predicted to witness a surge in need of blood and its products.

COMPETITIVE INSIGHTS
Some of the prominent companies in the market are, CSL Limited (CSL Behring), Haemonetics Corporation, Ortho Clinical Diagnostics, Terumo Corporation (Terumo BCT INC), Fresenius Kabi AG, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Demand For Blood And Other Blood Related Products Across The World
3.2.2. Surge In Geriatric Population Across The Globe
3.2.3. Rise In Blood Donations And Plasma Donations
3.2.4. Promising Government Regulations For Blood Screening
3.2.5. Progression In Blood Transfusion And Blood Screening Instruments
3.3. Key Restraints
3.3.1. High Cost Of Advanced Blood Collection Devices
3.3.2. Dearth Of Skilled Laboratory Professionals
4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’s Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Impact Of Covid – Blood Market
5. Market By Product
5.1. Whole Blood Collection
5.1.1. Whole Blood Collection Systems
5.1.2. Whole Blood Collection Reagents
5.2. Source Plasma Collection
5.2.1. Source Plasma Collection Systems
5.2.2. Source Plasma Collection Reagents
5.3. Blood Therapeutics
5.3.1. Intravenous Immunoglobulin (Ivig)
5.3.2. Albumin
5.3.3. Hyperimmune
5.3.4. Factor Viii
5.3.5. Factor Ix
5.3.6. Other Blood Therapeutics
5.4. Blood Typing
5.4.1. Blood Typing Systems
5.4.2. Blood Typing Reagents
5.5. Blood Screening
5.5.1. Blood Screening Systems
5.5.2. Blood Screening Reagents
5.6. Blood Processing Equipment
5.6.1. Blood Processing Equipment Systems
5.6.2. Blood Processing Equipment Reagents
6. Market By End-user
6.1. Blood & Blood Component Banks
6.2. Diagnostic Laboratories
6.3. Ambulatory Surgical Centers
6.4. Hospitals
6.5. Other End-users
7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. Japan
7.1.3. India
7.1.4. South Korea
7.1.5. Indonesia
7.1.6. Thailand
7.1.7. Vietnam
7.1.8. Australia & New Zealand
7.1.9. Rest Of Asia Pacific
8. Company Profiles
8.1. Abbott Laboratories
8.2. Bio-rad Laboratories Inc
8.3. Csl Limited (Csl Behring)
8.4. F Hoffmann-la Roche Ltd
8.5. Grifols International Sa
8.6. Haemonetics Corporation
8.7. Merck & Co Inc
8.8. Novo Nordisk A/S
8.9. Baxter International Inc
8.10. Becton Dickinson And Company
8.11. Fresenius Kabi Ag
8.12. Ortho Clinical Diagnostics
8.13. Terumo Corporation (Terumo Bct Inc)
8.14. Immucor Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook